NAFLD/NASHにおける高脂血症治療薬(HMG-CoA還元酵素阻害剤)の有効性とその役割について  [in Japanese] Efficacy of HMG-CoA reductase inhibitor for the treatment of nonalcoholic steatohepatitis with dyslipidemia  [in Japanese]

Search this Article

Author(s)

    • 兵庫 秀幸 HYOGO Hideyuki
    • 広島大学大学院分子病態制御内科学 Department of Medicine and Molecular Science, Graduate School of Biomedical Sciences, Hiroshima University
    • 田妻 進 TAZUMA Susumu
    • 広島大学大学院病態薬物治療学講座 Department of General Medicine, Hiroshima University Graduate School of Medical Science, Programs of Applied Medicine, Clinical Pharmacotherapy
    • 茶山 一彰 CHAYAMA Kazuaki
    • 広島大学大学院分子病態制御内科学 Department of Medicine and Molecular Science, Graduate School of Biomedical Sciences, Hiroshima University

Journal

  • 消化と吸収

    消化と吸収 34(3), 206-211, 2012-03-31

References:  4

Codes

  • NII Article ID (NAID)
    10030560853
  • NII NACSIS-CAT ID (NCID)
    AN00314946
  • Text Lang
    JPN
  • Article Type
    SHO
  • ISSN
    03893626
  • Data Source
    CJP 
Page Top